The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 975.00
Bid: 970.00
Ask: 975.00
Change: 20.00 (2.09%)
Spread: 5.00 (0.515%)
Open: 947.00
High: 982.00
Low: 946.00
Prev. Close: 955.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options & PDMR Dealing

26 Nov 2021 08:16

RNS Number : 7234T
CVS Group plc
26 November 2021
 

 

 

26 November 2021

CVS Group plc

("CVS", the "Company" and, together with its subsidiaries, the "Group")

 

Grant of Options under CVS Group plc SAYE Option Scheme & PDMR Dealing 

CVS Group plc (the "Company") announces that as part of its 2021/2022 Save As You Earn share scheme (the "SAYE Scheme"), which is open to all employees of the Group, the Executive Directors named below have elected to participate in the SAYE Scheme and have been granted SAYE Scheme options as follows:

 

Richard Fairman 310 SAYE scheme options

Robin Alfonso 291 SAYE scheme options

Ben Jacklin 310 SAYE scheme options

 

Eligible employees were invited to subscribe for options over the Company's ordinary shares of 0.2 pence each ("Ordinary Shares") with an exercise price of 1,974 pence per share, representing a 20% discount to the average closing middle market price for the three dealing days prior to 1 November 2021, being the invitation date.

 

In response to accepted invitations, a total of 215,022 SAYE Scheme options over Ordinary Shares were granted on 25 November 2021, equating to 0.30% of the current issued ordinary share capital. Subject to the rules of the SAYE Scheme, these options will be capable of exercise from the maturity date on 1 January 2025.

 

The notification below, made in accordance with the requirements of UK MAR, provides further detail.

 

Contacts:

 

 

 

CVS Group plc

via MHP Communications

Richard Fairman, CEO

 

Jenny Farrer, Company Secretary

 

 

 

Singer Capital Markets (Nominated Adviser & Broker)

+44 20 7496 3000

Aubrey Powell / Jen Boorer / Rachel Hayes

 

 

 

MHP Communications (Financial PR)

+44 20 3128 8549

Andrew Jaques / Rachel Mann / Charles Hirst

 

   

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Richard Fairman

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,974p

310

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

e)

Date of the transaction

25 November 2021

f)

Place of the transaction

Off market

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robin Alfonso

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,974p

291

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

e)

Date of the transaction

25 November 2021

f)

Place of the transaction

Off market

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ben Jacklin

2

Reason for the notification

a)

Position/status

Chief Operating Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

CVS Group plc

b)

LEI

213800J41XDQ2NX48O05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Options over Ordinary shares of 0.2 pence each

 

 

GB00B2863827

b)

Nature of the transaction

Grant of Options under the SAYE Scheme.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Exercise price of 1,974p

310

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

e)

Date of the transaction

25 November 2021

f)

Place of the transaction

Off market

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGIBDBDBDDGBL
Date   Source Headline
29th Jan 20217:00 amRNSTrading Update
6th Jan 20219:30 amRNSBlock Listing Application
5th Jan 20217:00 amRNSLong Term Incentive Plan Award
31st Dec 20207:00 amRNSExercise of Options
4th Dec 20209:34 amRNSGrant of Options under SAYE Scheme & PDMR Dealing
26th Nov 20203:49 pmRNSResult of AGM
26th Nov 20207:00 amRNSAGM Statement and Trading Update
23rd Nov 20207:00 amRNSHolding(s) in Company
9th Nov 20201:32 pmRNSLong Term Incentive Plan Awards & PDMR Dealing
6th Nov 20201:46 pmRNSHolding(s) in Company
4th Nov 20202:30 pmRNSPosting of Annual Report & Notice of AGM
30th Oct 20205:09 pmRNSExercise of Options
30th Sep 20207:00 amRNSExercise of Options
24th Sep 20207:00 amRNSFinal Results for the year ended 30 June 2020
4th Sep 202012:02 pmRNSPrice Monitoring Extension
28th Aug 20207:00 amRNSExercise of Options
18th Aug 20203:54 pmRNSHolding(s) in Company
31st Jul 20207:00 amRNSExercise of Options
24th Jul 20207:00 amRNSTrading Update
16th Jul 20207:00 amRNSBoard Appointment
30th Jun 202011:15 amRNSExercise of Options
26th Jun 20207:00 amRNSChange of Company Secretary
9th Jun 202012:29 pmRNSDirector/PDMR Shareholding
1st Jun 202011:50 amRNSExercise of Options
7th May 20209:10 amRNSHolding(s) in Company
30th Apr 202010:25 amRNSExercise of Options
14th Apr 20204:00 pmRNSHolding(s) in Company
9th Apr 202012:23 pmRNSHolding(s) in Company
2nd Apr 20202:29 pmRNSHolding(s) in Company
31st Mar 20201:42 pmRNSExercise of Options
30th Mar 202011:45 amRNSDirector/PDMR Shareholding
27th Mar 20202:52 pmRNSDirector/PDMR Shareholding
27th Mar 202012:02 pmRNSPrice Monitoring Extension
27th Mar 20209:54 amRNSFormatting Replacement: Interim Results
27th Mar 20207:00 amRNSInterim Results
20th Mar 20204:37 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSHolding(s) in Company
12th Mar 20209:34 amRNSHolding(s) in Company
9th Mar 20205:01 pmRNSHolding(s) in Company
9th Mar 20209:18 amRNSHolding(s) in Company
6th Mar 20205:27 pmRNSHolding(s) in Company
6th Mar 20202:47 pmRNSHolding(s) in Company
28th Feb 20207:00 amRNSExercise of Options
7th Feb 20207:00 amRNSTrading Update
31st Jan 20205:47 pmRNSOption exercise and block listing update
27th Jan 20204:12 pmRNSHolding(s) in Company
24th Jan 20204:22 pmRNSHolding(s) in Company
22nd Jan 20205:08 pmRNSHolding(s) in Company
20th Jan 20207:00 amRNSHolding(s) in Company
10th Jan 20203:46 pmRNSLong Term Incentive Plan Awards - replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.